nodes	percent_of_prediction	percent_of_DWPC	metapath
Iodixanol—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Iodixanol—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00354	0.00354	CcSEcCtD
Iodixanol—Dyspnoea—Teniposide—lymphatic system cancer	0.00352	0.00352	CcSEcCtD
Iodixanol—Confusional state—Fludarabine—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Iodixanol—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Iodixanol—Oedema—Fludarabine—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Iodixanol—Vomiting—Mechlorethamine—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Iodixanol—Nervous system disorder—Fludarabine—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Iodixanol—Apnoea—Methotrexate—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Iodixanol—Urinary tract infection—Carmustine—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Iodixanol—Rash—Mechlorethamine—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Iodixanol—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Iodixanol—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Iodixanol—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Iodixanol—Flushing—Bleomycin—lymphatic system cancer	0.00332	0.00332	CcSEcCtD
Iodixanol—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Iodixanol—Myocardial infarction—Vincristine—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Iodixanol—Feeling abnormal—Teniposide—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Iodixanol—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00324	0.00324	CcSEcCtD
Iodixanol—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Iodixanol—Chills—Bleomycin—lymphatic system cancer	0.00321	0.00321	CcSEcCtD
Iodixanol—Bone disorder—Methotrexate—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Iodixanol—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Iodixanol—Nausea—Mechlorethamine—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Iodixanol—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Iodixanol—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Iodixanol—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.00315	0.00315	CcSEcCtD
Iodixanol—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.00315	0.00315	CcSEcCtD
Iodixanol—Urticaria—Teniposide—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Iodixanol—Body temperature increased—Teniposide—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Iodixanol—Abdominal pain—Teniposide—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Iodixanol—Erythema—Bleomycin—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Iodixanol—Paraesthesia—Fludarabine—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Iodixanol—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Iodixanol—Dyspnoea—Fludarabine—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Iodixanol—Haematuria—Mitoxantrone—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Iodixanol—Oedema peripheral—Carmustine—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Iodixanol—Dyspepsia—Fludarabine—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Iodixanol—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Iodixanol—Visual impairment—Carmustine—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Iodixanol—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Iodixanol—Fatigue—Fludarabine—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Iodixanol—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Iodixanol—Pain—Fludarabine—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Iodixanol—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00296	0.00296	CcSEcCtD
Iodixanol—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00295	0.00295	CcSEcCtD
Iodixanol—Urethral disorder—Vincristine—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Iodixanol—Eye disorder—Carmustine—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Iodixanol—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Iodixanol—Flushing—Carmustine—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Iodixanol—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Iodixanol—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Iodixanol—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Iodixanol—Asthenia—Teniposide—lymphatic system cancer	0.00283	0.00283	CcSEcCtD
Iodixanol—Malaise—Bleomycin—lymphatic system cancer	0.00281	0.00281	CcSEcCtD
Iodixanol—Pruritus—Teniposide—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Iodixanol—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Iodixanol—Cardiac disorder—Vincristine—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Iodixanol—Body temperature increased—Fludarabine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Iodixanol—Mental disorder—Carmustine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Iodixanol—Erythema—Carmustine—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Iodixanol—Cough—Bleomycin—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Iodixanol—Angiopathy—Vincristine—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Iodixanol—Diarrhoea—Teniposide—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Iodixanol—Chest pain—Bleomycin—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Iodixanol—Coma—Methotrexate—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Iodixanol—Back pain—Carmustine—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Iodixanol—Discomfort—Bleomycin—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Iodixanol—Mental disorder—Vincristine—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Iodixanol—Chills—Mitoxantrone—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Iodixanol—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Iodixanol—Confusional state—Bleomycin—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Iodixanol—Oedema—Bleomycin—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Iodixanol—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Iodixanol—Erythema—Mitoxantrone—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Iodixanol—Back pain—Vincristine—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Iodixanol—Vomiting—Teniposide—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Iodixanol—Agitation—Carmustine—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Iodixanol—Asthenia—Fludarabine—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Iodixanol—Rash—Teniposide—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Iodixanol—Dermatitis—Teniposide—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Iodixanol—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Iodixanol—Headache—Teniposide—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Iodixanol—Pruritus—Fludarabine—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Iodixanol—Back pain—Mitoxantrone—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Iodixanol—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Iodixanol—Agitation—Vincristine—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Iodixanol—Hypotension—Bleomycin—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Iodixanol—Diarrhoea—Fludarabine—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Iodixanol—Convulsion—Carmustine—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Iodixanol—Hypertension—Carmustine—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Iodixanol—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Iodixanol—Nausea—Teniposide—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Iodixanol—Vertigo—Vincristine—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Iodixanol—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Iodixanol—Chest pain—Carmustine—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Iodixanol—Anxiety—Carmustine—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Iodixanol—Paraesthesia—Bleomycin—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Iodixanol—Malaise—Mitoxantrone—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Iodixanol—Dyspnoea—Bleomycin—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Iodixanol—Renal failure acute—Methotrexate—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Iodixanol—Convulsion—Vincristine—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Iodixanol—Hypertension—Vincristine—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Iodixanol—Confusional state—Carmustine—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Iodixanol—Oedema—Carmustine—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Iodixanol—Cough—Mitoxantrone—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Iodixanol—Vomiting—Fludarabine—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Iodixanol—Convulsion—Mitoxantrone—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Iodixanol—Rash—Fludarabine—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Iodixanol—Dermatitis—Fludarabine—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Iodixanol—Hypertension—Mitoxantrone—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Iodixanol—Pain—Bleomycin—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Iodixanol—Headache—Fludarabine—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Iodixanol—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Iodixanol—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Iodixanol—Chest pain—Mitoxantrone—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Iodixanol—Anxiety—Mitoxantrone—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Iodixanol—Discomfort—Mitoxantrone—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Iodixanol—Oedema—Vincristine—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Iodixanol—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Iodixanol—Feeling abnormal—Bleomycin—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Iodixanol—Confusional state—Mitoxantrone—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Iodixanol—Nervous system disorder—Vincristine—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Iodixanol—Hypotension—Carmustine—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Iodixanol—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Iodixanol—Oedema—Mitoxantrone—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Iodixanol—Nausea—Fludarabine—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Iodixanol—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Iodixanol—Shock—Mitoxantrone—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Iodixanol—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Iodixanol—Urticaria—Bleomycin—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Iodixanol—Body temperature increased—Bleomycin—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Iodixanol—Insomnia—Carmustine—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Iodixanol—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.002	0.002	CcSEcCtD
Iodixanol—Paraesthesia—Carmustine—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Iodixanol—Hypotension—Vincristine—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Iodixanol—Dyspnoea—Carmustine—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Iodixanol—Somnolence—Carmustine—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Iodixanol—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Iodixanol—Hypotension—Mitoxantrone—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Iodixanol—Insomnia—Vincristine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Iodixanol—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Iodixanol—Paraesthesia—Vincristine—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Iodixanol—Pain—Carmustine—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Iodixanol—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Iodixanol—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Iodixanol—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Iodixanol—Somnolence—Mitoxantrone—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Iodixanol—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Iodixanol—Feeling abnormal—Carmustine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Iodixanol—Fatigue—Vincristine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Iodixanol—Asthenia—Bleomycin—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Iodixanol—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Iodixanol—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Iodixanol—Pain—Vincristine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Iodixanol—Asthma—Methotrexate—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Iodixanol—Pruritus—Bleomycin—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Iodixanol—Fatigue—Mitoxantrone—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Iodixanol—Pain—Mitoxantrone—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Iodixanol—Body temperature increased—Carmustine—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Iodixanol—Abdominal pain—Carmustine—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Iodixanol—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Iodixanol—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Iodixanol—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Iodixanol—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Iodixanol—Abdominal pain—Vincristine—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Iodixanol—Body temperature increased—Vincristine—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Iodixanol—Urticaria—Mitoxantrone—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Iodixanol—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Iodixanol—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Iodixanol—Vomiting—Bleomycin—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Iodixanol—Drowsiness—Methotrexate—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Iodixanol—Rash—Bleomycin—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Iodixanol—Dermatitis—Bleomycin—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Iodixanol—Asthenia—Carmustine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Iodixanol—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Iodixanol—Haematuria—Methotrexate—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Iodixanol—Asthenia—Vincristine—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Iodixanol—Diarrhoea—Carmustine—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Iodixanol—Nausea—Bleomycin—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Iodixanol—Asthenia—Mitoxantrone—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Iodixanol—Dizziness—Carmustine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Iodixanol—Diarrhoea—Vincristine—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Iodixanol—Pharyngitis—Methotrexate—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Iodixanol—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Iodixanol—Urethral disorder—Methotrexate—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Iodixanol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Iodixanol—Vomiting—Carmustine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Iodixanol—Dizziness—Vincristine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Iodixanol—Rash—Carmustine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Iodixanol—Dermatitis—Carmustine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Iodixanol—Visual impairment—Methotrexate—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Iodixanol—Headache—Carmustine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Iodixanol—Eye disorder—Methotrexate—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Iodixanol—Tinnitus—Methotrexate—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Iodixanol—Vomiting—Vincristine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Iodixanol—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Iodixanol—Rash—Vincristine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Iodixanol—Dermatitis—Vincristine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Iodixanol—Headache—Vincristine—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Iodixanol—Nausea—Carmustine—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Iodixanol—Angiopathy—Methotrexate—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Iodixanol—Vomiting—Mitoxantrone—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Iodixanol—Immune system disorder—Methotrexate—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Iodixanol—Rash—Mitoxantrone—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Iodixanol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Iodixanol—Chills—Methotrexate—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Iodixanol—Headache—Mitoxantrone—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Iodixanol—Mental disorder—Methotrexate—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Iodixanol—Erythema—Methotrexate—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Iodixanol—Nausea—Vincristine—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Iodixanol—Dysgeusia—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Iodixanol—Nausea—Mitoxantrone—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Iodixanol—Back pain—Methotrexate—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Iodixanol—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Iodixanol—Malaise—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Iodixanol—Vertigo—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Iodixanol—Cough—Methotrexate—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Iodixanol—Convulsion—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Iodixanol—Arthralgia—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Iodixanol—Chest pain—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Iodixanol—Discomfort—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Iodixanol—Confusional state—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Iodixanol—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Iodixanol—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Iodixanol—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000994	0.000994	CcSEcCtD
Iodixanol—Hypotension—Methotrexate—lymphatic system cancer	0.000961	0.000961	CcSEcCtD
Iodixanol—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000937	0.000937	CcSEcCtD
Iodixanol—Insomnia—Methotrexate—lymphatic system cancer	0.00093	0.00093	CcSEcCtD
Iodixanol—Paraesthesia—Methotrexate—lymphatic system cancer	0.000923	0.000923	CcSEcCtD
Iodixanol—Dyspnoea—Methotrexate—lymphatic system cancer	0.000917	0.000917	CcSEcCtD
Iodixanol—Somnolence—Methotrexate—lymphatic system cancer	0.000914	0.000914	CcSEcCtD
Iodixanol—Dyspepsia—Methotrexate—lymphatic system cancer	0.000905	0.000905	CcSEcCtD
Iodixanol—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000888	0.000888	CcSEcCtD
Iodixanol—Fatigue—Methotrexate—lymphatic system cancer	0.000887	0.000887	CcSEcCtD
Iodixanol—Pain—Methotrexate—lymphatic system cancer	0.000879	0.000879	CcSEcCtD
Iodixanol—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000847	0.000847	CcSEcCtD
Iodixanol—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000841	0.000841	CcSEcCtD
Iodixanol—Urticaria—Methotrexate—lymphatic system cancer	0.000817	0.000817	CcSEcCtD
Iodixanol—Abdominal pain—Methotrexate—lymphatic system cancer	0.000813	0.000813	CcSEcCtD
Iodixanol—Body temperature increased—Methotrexate—lymphatic system cancer	0.000813	0.000813	CcSEcCtD
Iodixanol—Asthenia—Methotrexate—lymphatic system cancer	0.000738	0.000738	CcSEcCtD
Iodixanol—Pruritus—Methotrexate—lymphatic system cancer	0.000728	0.000728	CcSEcCtD
Iodixanol—Diarrhoea—Methotrexate—lymphatic system cancer	0.000704	0.000704	CcSEcCtD
Iodixanol—Dizziness—Methotrexate—lymphatic system cancer	0.00068	0.00068	CcSEcCtD
Iodixanol—Vomiting—Methotrexate—lymphatic system cancer	0.000654	0.000654	CcSEcCtD
Iodixanol—Rash—Methotrexate—lymphatic system cancer	0.000648	0.000648	CcSEcCtD
Iodixanol—Dermatitis—Methotrexate—lymphatic system cancer	0.000648	0.000648	CcSEcCtD
Iodixanol—Headache—Methotrexate—lymphatic system cancer	0.000644	0.000644	CcSEcCtD
Iodixanol—Nausea—Methotrexate—lymphatic system cancer	0.000611	0.000611	CcSEcCtD
